Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual versus vaginal misoprostol for induction of labour
PACTR202509567116777Phase 3Not yet recruiting
- Sponsor
- Tivkaa Terna David
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of misoprostol (2 arms), sponsored by Tivkaa Terna David. Primary endpoint: Induction-to-delivery interval. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
misoprostol
Beyond the preview
Go deeper on PACTR202509567116777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202509567116777.